Simplex Trading’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Simplex Trading’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-44	Closed	-$1K	–	8930
2024 Q3	$1K	Buy	44 +29	+193%	+$1.3K	﹤0.01%	8189
2024 Q2	$0	Buy	+15	New	+$627	﹤0.01%	9152
2022 Q4	–	Sell	-578	Closed	-$29K	–	9613
2022 Q3	$29K	Buy	578 +384	+198%	+$21.7K	﹤0.01%	7104
2022 Q2	$9K	Sell	194 -1,815	-90%	-$92K	﹤0.01%	8364
2022 Q1	$120K	Buy	2,009 +1,890	+1,588%	+$119K	﹤0.01%	5890
2021 Q4	$9K	Sell	119 -3	-2%	-$252	﹤0.01%	9115
2021 Q3	$12K	Hold	122	–	–	﹤0.01%	8815
2021 Q2	$12K	Buy	122 +82	+205%	+$7.27K	﹤0.01%	8979
2021 Q1	$3K	Buy	+40	New	+$3.95K	﹤0.01%	8363

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Simplex Trading's GNOM Position: Q4 2024 in Review

Simplex Trading sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2024, closing a stake of 44 shares — an estimated $1K sold.

Simplex Trading first reported a position in GNOM in Q1 2021 and held it in 9 quarters. The position peaked at $120K in Q1 2022. 68 funds tracked by Wall St. Rank hold GNOM as of Q4 2024.

Simplex Trading reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Simplex Trading sold 44 Global X Genomics & Biotechnology ETF shares in Q4 2024, an estimated $1K.
Simplex Trading first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 9 quarters.
Simplex Trading's Global X Genomics & Biotechnology ETF position peaked at $120K in Q1 2022.
68 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.